Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. J Natl Cancer Inst 2008; 100: 388-398.

Published: 1st January 2008

Authors: Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S et al.

Conclusion

 The trial included 258 patients followed for a median of 72.8 months after their surgery. The addition of chemotherapy did not improve disease-free survival (hazard ratio 0.92, 95 per cent confidence interval 0.66 to 1.27) or overall survival (0.9, 0.64 to 1.26).



 

Pubmed Link

Your comments

0 Comments